Position in AZN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,288,334
-$70,022 QoQ
Shares Held
12,068
+0.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#500
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SYON CAPITAL LLC holds $48,543,750 across 15 Drug Manufacturers - General names. AZN ranks #7 (4.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
13,135 | $15,754,514 | |
| 2 | JNJ |
Johnson & Johnson
|
32,155 | $8,166,405 | |
| 3 | ABBV |
AbbVie Inc.
|
27,228 | $6,851,653 | |
| 4 | MRK |
Merck & Co., Inc.
|
29,362 | $3,773,017 | |
| 5 | AMGN |
Amgen Inc
|
8,459 | $3,063,173 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
20,463 | $2,585,295 | |
| 7 | AZN |
Astrazeneca PLC
This page
|
12,068 | $2,288,334 | |
| 8 | GSK |
GSK plc
|
29,588 | $1,551,002 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,288,334 | 12,068 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,358,356 | 11,958 | Shares | Sole | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||